Development of iron-containing multiwalled carbon nanotubes for MR-guided laser-induced thermotherapy

Nanomedicine

Volumn 6, Issue 8, 2011, Pages 1341-1352

  Ding, Xuanfeng ^a,b   Singh, Ravi ^b   Burke, Andrew ^b   Hatcher, Heather ^b   Olson, John ^b   Kraft, Robert A ^b   Schmid, Michael ^a   Carroll, David ^a,b   Bourland, J Daniel ^a,b   Akman, Steven ^b   Torti, Frank M ^b   Torti, Suzy V ^b  

^a WAKE FOREST UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

cancer; contrast agent; in vivo; laser; MRI; nanotube; T2; thermal therapy

Indexed keywords

CONTRAST MEDIUM; FERROCENE; IRON; MULTI WALLED NANOTUBE; NANOMATERIAL; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL MODIFICATION; CHEMICAL VAPOR DEPOSITION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISPERSION; HEATING; HYPERTHERMIC THERAPY; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; KIDNEY CARCINOMA; MOUSE; NEAR INFRARED LASER IRRADIATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SUSPENSION; SYNTHESIS; TUMOR ABLATION; VAPOR;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CONTRAST MEDIA; FEMALE; HYPERTHERMIA, INDUCED; IRON; KIDNEY NEOPLASMS; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; NANOTUBES, CARBON;

EID: 80155214228     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.37     Document Type: Article

References (47)

1. Wagner V, Dullaart A, Bock AK, Zweck A. The emerging nanomedicine landscape. Nat. Biotechnol. 24(10), 1211-1217 (2006).
2. Lacerda L, Raffa S, Prato M, Bianco A, Kostarelos K. Cell-penetrating CNTs for delivery of therapeutics. Nano. Today 2(6), 38-43 (2007).
3. Raffa V, Ciofani G, Nitodas S et al. Can the properties of carbon nanotubes influence their internalization by living cells? Carbon 46(12), 1600-1610 (2008).
4. Singh R, Pantarotto D, McCarthy D et al. Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors. J. Am. Chem. Soc. 127(12), 4388-4396 (2005).
5. Shi DL. Integrated multifunctional nanosystems for medical diagnosis and Treatment. Adv. Func. Mater. 19(21), 3356-3373 (2009).
6. Avedisian CT, Cavicchi RE, Mceuen PL, Zhou X. Nanoparticles for cancer treatment: role of heat transfer. Ann. NY Acad. Sci. 1161, 62-73 (2009).
7. Harris DL, Bawa R. The carbon nanotube patent landscape in nanomedicine: an expert opinion. Expert Opin. Ther. Pat. 17(9), 1165-1174 (2007).
8. Klingeler R, Hampel S, Buchner B. Carbon nanotube based biomedical agents for heating, temperature sensoring and drug delivery. Int. J. Hyperthermia 24(6), 496-505 (2008).
9. Kostarelos K, Bianco A, Prato M. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat. Nanotechnol. 4(10), 627-633 (2009).
10. Murday JS, Siegel RW, Stein J, Wright JF. Translational nanomedicine: status assessment and opportunities. Nanomedicine: NBM 5(3), 251-273 (2009).
11. Portney NG, Ozkan M. Nano-oncology: drug delivery, imaging, and sensing. Anal. Bioanal. Chem. 384(3), 620-630 (2006).
12. Teker K. Bioconjugated carbon nanotubes for targeting cancer biomarkers. Mater. Sci. Eng. B 153(1-3), 83-87 (2008).
13. ONeal DP, Hirsch LR, Halas NJ, Payne JD, West JL. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 209(2), 171-176 (2004).
14. Kangasniemi M, McNichols RJ, Bankson JA, Gowda A, Price RE, Hazle JD. Thermal therapy of canine cerebral tumors using a 980 nm diode laser with MR temperature-sensitive imaging feedback. Lasers Surg. Med. 35(1), 41-50 (2004).
15. Nikfarjam M, Muralidharan V, Christophi C. Mechanisms of focal heat destruction of liver tumors. J. Surg. Res. 127(2), 208-223 (2005).
16. Manthe RL, Foy SP, Krishnamurthy N, Sharam B, Labhasetwar VD. Tumor ablation and nanotechnology. Mol. Pharm. (2010).
17. Ryan TP, Turner PF, Hamilton B: Interstitial microwave transition from hyperthermia to ablation: historical perspectives and current trends in thermal therapy. Int. J. Hyperthermia 26(5), 415-433 (2010).
18. Widmann G, Bodner G, Bale R. Tumour ablation: technical aspects. Cancer Imaging 9(Spec. No A), S63-S67 (2009).
19. Burke A, Ding X, Singh R et al. Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation. Proc. Natl Acad. Sci. USA 106(31), 12897-12902 (2009).
20. Chen WR, Korbelik M, Bartels KE, Liu H, Sun J, Nordquist RE. Enhancement of laser cancer treatment by a chitosan-derived immunoadjuvant. Photochem. Photobiol. 81(1), 190-195 (2005).
21. Gnyawali SC, Chen Y, Wu F et al. Temperature measurement on tissue surface during laser irradiation. Med. Biol. Eng. Comput. 46(2), 159-168 (2008).
22. Al Faraj A, Cieslar K, Lacroix G, Gaillard S, Canot-Soulas E, Cremillieux Y. In vivo imaging of carbon nanotube biodistribution using magnetic resonance imaging. Nano. Letters 9(3), 1023-1027 (2009).
23. Bomat-Miguel O, Morales MP, Tartaj P et al. Fe-based nanoparticulate metallic alloys as contrast agents for magnetic resonance imaging. Biomaterials 26(28), 5695-5703 (2005).
24. Bulte JWM, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 17(7), 484-499 (2004).
25. Cunningham CH, Arai T, Yang PC, Mcconnell MV, Pauly JM, Conolly SM. Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn. Reson. Med. 53(5), 999-1005 (2005).
26. Fahlvik AK, Klaveness J, Stark DD. Iron oxides as MR imaging contrast agents. J Magn. Reson. Imaging 3(1), 187-194 (1993).
27. Mani V, Briley-Saebo KC, Itskovich VV, Samber DD, Fayad ZA. Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T. Magn. Reson. Med. 55(1), 126-135 (2006).
28. Saini S, Stark DD, Hahn PF, Wittenberg J, Brady TJ, Ferrucci JT Jr. Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology 162(1 Pt 1), 211-216 (1987).
29. Kovjazin R, Eldar T, Patya M, Vanichkin A, Lander HM, Novogrodsky A. Ferrocene-induced lymphocyte activation and antitumor activity is mediated by redox-sensitive signaling. FASEB. J. 17(1), 467-469 (2003).
30. Ferle-Vidovic A, Potjak-Blazi M, Rapic V, Skare D. Ferrocenes (F168, F169) and fero-sorbitol-citrate (FSC): potential anticancer drugs. Cancer. Biother. Radiopharm. 15(6), 617-624 (2000).
31. Schechter B, Caldwell G, Neuse EW. A preliminary study of the toxicological properties of selected polymer-ferrocene conjugates. J. Inorg. Organomet. Polymer Mater. 10(4), 177-188 (2000).
32. Nikula KJ, Sun JD, Barr EB et al. 13-week, repeated inhalation exposure of F344/N rats and B6c3f1 mice to ferrocene. Fundam. Appl. Toxicol. 21(2), 127-139 (1993).
33. Torti SV, Byrne F, Whelan O et al. Thermal ablation therapeutics based on CNx multi-walled nanotubes. Int. J. Nanomedicine 2(4), 707-714 (2007).
34. Dowlatshahi K, Dieschbourg JJ, Bloom KJ. Laser therapy of breast cancer with 3-year follow-up. Breast J. 10(3), 240-243 (2004).
35. Huang HC, Rege K, Heys JJ. Spatiotemporal temperature distribution and cancer cell death in response to extracellular hyperthermia induced by gold nanorods. ACS Nano. 4(5), 2892-2900 (2010).
36. Park JH, Von Maltzahn G, Xu MJ et al. Cooperative nanomaterial system to sensitize, target, and treat tumors. Proc. Natl Acad. Sci. USA 107(3), 981-986 (2010).
37. Day ES, Morton JG, West JL. Nanoparticles for thermal cancer therapy. J. Biomech. Eng. 131(7), 074001 (2009).
38. Krupskaya Y, Mahn C, Parameswaran A et al. Magnetic study of iron-containing carbon nanotubes: feasibility for magnetic hyperthermia. J. Magn. Magn. Mater. 321(24), 4067-4071 (2009).
39. Mack MG, Straub R, Eichler K et al. Percutaneous MR imaging-guided laser-induced thermotherapy of hepatic metastases. Abdom. Imaging 26(4), 369-374 (2001).
40. Mack MG, Straub R, Eichler K, Sollner O, Lehnert T, Vogl TJ. Breast cancer metastases in liver: laser-induced interstitial thermotherapy - local tumor control rate and survival data. Radiology 233(2), 400-409 (2004).
41. Mack MG, Vogl TJ. MR-guided ablation of head and neck tumors. Neuroimaging Clin. N. Am. 14(4), 853-859 (2004).
42. Meister D, Hubner F, Mack M, Vogl TJ. MR thermometry for laser-induced thermotherapy at 1.5 tesla. Rofo 179(5), 497-505 (2007).
43. Ferrari FS, Megliola A, Scorzelli A et al. Treatment of small HCC through radiofrequency ablation and laser ablation. Comparison of techniques and long-term results. Radiol. Med. 112(3), 377-393 (2007).
44. Weissleder R. A clearer vision for in vivo imaging. Nat. Biotechnol. 19(4), 316-317 (2001).
45. Deng XY, Wu F, Liu Z et al. The splenic toxicity of water soluble multi-walled carbon nanotubes in mice. Carbon 47(6), 1421-1428 (2009).
46. Qu GB, Bai YH, Zhang Y, Jia Q, Zhang WD, Yan B. The effect of multiwalled carbon nanotube agglomeration on their accumulation in and damage to organs in mice. Carbon 47(8), 2060-2069 (2009).
47. Yang ST, Wang X, Jia G et al. Long-term accumulation and low toxicity of single-walled carbon nanotubes in intravenously exposed mice. Toxicol. Lett. 181(3), 182-189 (2008).